Bristol-Myers Squibb Company (BMY) has a consensus analyst rating of Hold, based on 41 analysts covering the stock. Of those, 19 recommend buying, 20 recommend holding, and 2 recommend selling.
The analyst consensus price target for BMY is $62.73, representing a +8.0% upside from the current price of $58.08. Price targets range from a low of $40.00 to a high of $75.00.
